These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23503893)
1. Cellular events during arthritis-induced hyperalgesia are mediated by interleukin-6 and p38 MAPK and their effects on the expression of spinal mu-opioid receptors. Zaringhalam J; Tekieh E; Manaheji H; Akhtari Z Rheumatol Int; 2013 Sep; 33(9):2291-9. PubMed ID: 23503893 [TBL] [Abstract][Full Text] [Related]
2. Relationship between serum IL10 level and p38MAPK enzyme activity on behavioral and cellular aspects of variation of hyperalgesia during different stages of arthritis in rats. Zaringhalam J; Akhtari Z; Eidi A; Ruhani AH; Tekieh E Inflammopharmacology; 2014 Feb; 22(1):37-44. PubMed ID: 23765634 [TBL] [Abstract][Full Text] [Related]
3. Bidirectional effects of serum TNF alpha level and spinal p38MAPK phosphorylation on hyperalgesia variation during CFA-induced arthritis. Akhtari Z; Zaringhalam J; Eidi A; Manaheji H; Tekieh E EXCLI J; 2012; 11():373-85. PubMed ID: 27418913 [TBL] [Abstract][Full Text] [Related]
4. Increased serum IL-6 level time-dependently regulates hyperalgesia and spinal mu opioid receptor expression during CFA-induced arthritis. Tekieh E; Zaringhalam J; Manaheji H; Maghsoudi N; Alani B; Zardooz H EXCLI J; 2011; 10():23-33. PubMed ID: 27857662 [TBL] [Abstract][Full Text] [Related]
5. Spinal mu-opioid receptor expression and hyperalgesia with dexamethasone in chronic adjuvant-induced arthritis in rats. Zaringhalam J; Manaheji H; Mghsoodi N; Farokhi B; Mirzaiee V Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1309-15. PubMed ID: 18671722 [TBL] [Abstract][Full Text] [Related]
6. Serum IL-10 involved in morphine tolerance development during adjuvant-induced arthritis. Zaringhalam J; Hormozi A; Tekieh E; Razavi J; Khanmohammad R; Golabi S J Physiol Biochem; 2014 Jun; 70(2):497-507. PubMed ID: 24643510 [TBL] [Abstract][Full Text] [Related]
7. Spinal endomorphins attenuate burn-injury pain in male mice by inhibiting p38 MAPK signaling pathway through the mu-opioid receptor. Zhang T; Zhang R; Xu B; Zhang M; Zhang Q; Li N; Qiu Y; Chen D; Xu K; Xiao J; Zhang N; Fang Q Eur J Pharmacol; 2021 Jul; 903():174139. PubMed ID: 33933465 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. Sung CS; Wen ZH; Chang WK; Chan KH; Ho ST; Tsai SK; Chang YC; Wong CS J Neurochem; 2005 Aug; 94(3):742-52. PubMed ID: 16033422 [TBL] [Abstract][Full Text] [Related]
9. Cdk5 contributes to inflammation-induced thermal hyperalgesia mediated by the p38 MAPK pathway in microglia. Fang-Hu ; Zhang HH; Yang BX; Huang JL; Shun JL; Kong FJ; Peng-Xu ; Chen ZG; Lu JM Brain Res; 2015 Sep; 1619():166-75. PubMed ID: 25819553 [TBL] [Abstract][Full Text] [Related]
10. Sigma-1 receptor-mediated increase in spinal p38 MAPK phosphorylation leads to the induction of mechanical allodynia in mice and neuropathic rats. Moon JY; Roh DH; Yoon SY; Kang SY; Choi SR; Kwon SG; Choi HS; Han HJ; Beitz AJ; Lee JH Exp Neurol; 2013 Sep; 247():383-91. PubMed ID: 23333567 [TBL] [Abstract][Full Text] [Related]
11. p38 stress-activated protein kinase inhibitor reverses bradykinin B(1) receptor-mediated component of inflammatory hyperalgesia. Ganju P; Davis A; Patel S; Núñez X; Fox A Eur J Pharmacol; 2001 Jun; 421(3):191-9. PubMed ID: 11516436 [TBL] [Abstract][Full Text] [Related]
12. Blockade of peripheral P2Y1 receptors prevents the induction of thermal hyperalgesia via modulation of TRPV1 expression in carrageenan-induced inflammatory pain rats: involvement of p38 MAPK phosphorylation in DRGs. Kwon SG; Roh DH; Yoon SY; Moon JY; Choi SR; Choi HS; Kang SY; Han HJ; Beitz AJ; Lee JH Neuropharmacology; 2014 Apr; 79():368-79. PubMed ID: 24333674 [TBL] [Abstract][Full Text] [Related]
13. Regulation of peripheral inflammation by spinal p38 MAP kinase in rats. Boyle DL; Jones TL; Hammaker D; Svensson CI; Rosengren S; Albani S; Sorkin L; Firestein GS PLoS Med; 2006 Sep; 3(9):e338. PubMed ID: 16953659 [TBL] [Abstract][Full Text] [Related]
14. Electroacupuncture attenuates spinal nerve ligation-induced microglial activation mediated by p38 mitogen-activated protein kinase. Liang Y; Du JY; Qiu YJ; Fang JF; Liu J; Fang JQ Chin J Integr Med; 2016 Sep; 22(9):704-13. PubMed ID: 25847774 [TBL] [Abstract][Full Text] [Related]
15. Clonidine, an alpha-2 adrenoceptor agonist relieves mechanical allodynia in oxaliplatin-induced neuropathic mice; potentiation by spinal p38 MAPK inhibition without motor dysfunction and hypotension. Yeo JH; Yoon SY; Kim SJ; Oh SB; Lee JH; Beitz AJ; Roh DH Int J Cancer; 2016 May; 138(10):2466-76. PubMed ID: 26704560 [TBL] [Abstract][Full Text] [Related]
16. Long term treatment by mesenchymal stem cells conditioned medium modulates cellular, molecular and behavioral aspects of adjuvant-induced arthritis. Nazemian V; Manaheji H; Sharifi AM; Zaringhalam J Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):19-26. PubMed ID: 29412789 [TBL] [Abstract][Full Text] [Related]
18. The Effect of Orally Administered Probiotics on the Behavioral, Cellular, and Molecular Aspects of Adjuvant-Induced Arthritis. Shadnoush M; Nazemian V; Manaheji H; Zaringhalam J Basic Clin Neurosci; 2018; 9(5):325-336. PubMed ID: 30719247 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats. Koch DA; Silva RB; de Souza AH; Leite CE; Nicoletti NF; Campos MM; Laufer S; Morrone FB Rheumatology (Oxford); 2014 Mar; 53(3):425-32. PubMed ID: 24241037 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of spinal p38 MAPK prevents articular neutrophil infiltration in experimental arthritis via sympathetic activation. Kanashiro A; Franchin M; Bassi GS; Reis Santana DA; Cunha TM; Cunha FQ; Ulloa L; Rodrigues GJ Fundam Clin Pharmacol; 2018 Apr; 32(2):155-162. PubMed ID: 29206314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]